(Q37039472)

17 August 2017

HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment (English)

1 reference

Duchenne muscular dystrophy

17 August 2017

1 reference

Correction for Colussi et al., HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment

inferred from title

corrigendum / erratum

0 references

author

Carmela Dell'Aversana

Carmela Dell'Aversana

17

0 references

Jessica Rosati

Jessica Rosati

5

0 references

Chiara Mozzetta

Chiara Mozzetta

2

0 references

Germana Zaccagnini

Germana Zaccagnini

9

0 references

Aymone Gurtner

Aymone Gurtner

3

0 references

Claudia Colussi

Claudia Colussi

1

0 references

Giulia Piaggio

Giulia Piaggio

13

0 references

Fabio Martelli

Fabio Martelli

12

0 references

Pier Lorenzo Puri

Pier Lorenzo Puri

21

0 references

Lucia Altucci

Lucia Altucci

18

0 references

Carlo Gaetano

Carlo Gaetano

22

0 references

Antonello Mai

Antonello Mai

19

0 references

Emilio Clementi

16

Emilio Clementi

1 reference

17 August 2017

Maurizio C. Capogrossi

20

Maurizio C Capogrossi

1 reference

17 August 2017

6

Stefania Straino

1 reference

17 August 2017

4

Barbara Illi

1 reference

17 August 2017

7

Gianluca Ragone

1 reference

17 August 2017

Christian Steinkühler

15

Christian Steinkuhler

1 reference

17 August 2017

14

Paola Gallinari

1 reference

17 August 2017

8

Mario Pescatori

1 reference

17 August 2017

10

Annalisa Antonini

1 reference

17 August 2017

Giulia Minetti

11

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Proceedings of the National Academy of Sciences of the United States of America

17 August 2017

1 reference

17 August 2017

105

1 reference

17 August 2017

19183-19187

1 reference

17 August 2017

49

1 reference

S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

How corticosteroids control inflammation: Quintiles Prize Lecture 2005

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Physiology of nitric oxide in skeletal muscle

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Functional improvement of dystrophic muscle by myostatin blockade.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614736

Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19047631

12 December 2020

inferred from PubMed ID database lookup

Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19047631

12 December 2020

inferred from PubMed ID database lookup

Loss of myostatin attenuates severity of muscular dystrophy in mdx mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19047631

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1073/PNAS.0805514105

1 reference

17 August 2017

0 references

1 reference

17 August 2017

1 reference